Created at 12:58 a.m. Jul, 22, 2026
Author: anm973
Related Note: 1485382362549 6
Rationale for change

While hyperkalemia and malignant hyperthermia are recognized complications of succinylcholine use, hypercalcemia is not a recognized complication, according to several sources including UWorld, Bootcamp, Amboss. Further check in outside literature like OpenEvidence confirms this.

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#B&B::15_MSK::02_Cell_Bio::01_Skeletal_Muscle::Extra #AK_Other::AnKing_Image::!Subjects::Psychiatry::Malignant_hyperthermia_vs_neuroleptic_malignant_syndrome #AK_Step1_v12::#B&B::01_Anesthesia::01_General::01_Inhaled_Anesthetics::Extra #AK_Step2_v12::#UWorld::Step::4428 #AK_Step2_v12::#AMBOSS::230T3f #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::07_Cholinomimetic_agents::*Indirect_Agonists::Neuromuscular_Junction_Blockage::Depolarizing #AK_Step2_v12::#SketchySurgery::01_Preoperative_&_Postoperative_Surgical_Considerations::02_Postoperative::01_Postoperative_Surgical_Fevers #AK_Step1_v12::#B&B::01_Anesthesia::01_General::04_Neuromuscular_Blockers::Extra #AK_Step1_v12::#AMBOSS::y_0dIi #AK_Other::AnKing_Image::Mujeeb::Malignant_hyperthermia_vs_neuroleptic_malignant_syndrome #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::06_Pharm::11_Neuromuscular_blocking_drugs #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::08_Muscle_Relaxants::01_Skeletal_Muscle_Relaxants #AK_Step1_v12::#Physeo::09_Pharm::14_Neuro::19_Neuromuscular_Blocking_Drugs #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#UWorld::COMLEX::25405 #AK_Other::Only_Step_1 #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::06_Pharm::11_Neuromuscular_blocking_drugs::01_Depolarizing_neuromuscular_blocking_drugs::*Depolarizing #AK_Step1_v12::#Bootcamp::Musculoskeletal::01_Skeletal_Muscle::04_Malignant_Hyperthermia #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#AMBOSS::8y0OSi #AK_Step2_v12::#B&B::16_Surgery_and_Anesthesia::02_Anesthesia::03_Neuromuscular_Blockers::Extra #AK_Step1_v12::#UWorld::Step::8481 #AK_Step2_v12::#AMBOSS::aN0Q-T #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::01_Anesthetics_&_Analgesics::02_Inhaled_Anesthetics_&_Dantrolene #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#OME::PreClinical::General_Physiology::Skeletal_Muscle #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::FA-Neuro #AK_Step1_v12::#Pixorize::03_Pharmacology::15_Anesthetics::05_Succinylcholine